Posted inLife Sciences │ Volume 2 Issue 2

Preliminary Discussion About Ascites

Full Article - PDF

Publication: 15/12/2023

Page: 1-14

Volume 2 Issue 2

How to cite 

 

Gao, J. (2023). Preliminary Discussion About Ascites. IRESPUB Journal of Life Sciences, 2(2), 1-14. 

Jian Gao

International Education School, China Medical University, Shenyang, Liaoning, P. R. China 110122

 
Abstract

This article introduces ascites, which is one of the common clinical manifestations in the work of clinicians, and its pathological mechanism is very complex, involving multiple clinical disciplines and systems. This article will gradually discuss the causes, clinical manifestations, and diseases related to ascites. In particular, two thirds of patients with liver cirrhosis will have ascites within 10 years. According to the clinical practice class held in the Department of Gastroenterology at the undergraduate stage, the teacher explained and commented on the actual cases, and the author read the literature after the class. Finally, this article was formed, hoping to have a better understanding of ascites related diseases in the future.

 
Keywords

ascites; liver cirrhosis; etiology; clinical manifestations; diagnosis; initial treatment; treatment strategy.

 
References
  1. Zhao Zh K, Huang L, Wang L, et al. (2021). One case of hypothyroidism and ascites formation caused by anti-contact protein related protein 2 antibody encephalitis combined with Hashimoto’s thyroiditis (in Chinese). Chinese Journal of Neuroimmunology and Neurology, 28 (2): 171-172.
  2. Tian Y, Hong J, Wang B Q, et al. (2021). Current status and prospect of long-term albumin therapy in patients with liver cirrhosis ascites (in Chinese). Journal of Clinical Hepatobiliary Diseases, 37 (1): 173-175.
  3. Shan H Sh, Jiang M M, Xu H, et al. (2021). Analysis of the effect of modified transjugular intrahepatic portosystemic shunt in the treatment of intractable ascites caused by Budd Chiari syndrome (in Chinese). Journal of Interventional Radiology, 30 (3): 235-238.
  4. Chen S P, Xia Y F, Jiang H H, etc. (2021). The influence of ascites derived exosomes on the dryness and invasion of epithelial ovarian cancer stem cell like cells (in Chinese). Chinese Journal of Obstetrics and Gynecology, 56 (5): 349-357.
  5. He T H, Zhang J, Yin Zh N, et al. (2021). Study on the correlation between ascitic lymphocyte components and clinical characteristics of high-grade serous ovarian cancer (in Chinese). Chinese Medical Journal, 101 (30): 2375-2381.
  6. Lv N H, Zhu Zh H. (2021). Ascites and intestinal diseases (in Chinese). Chinese Journal of Digestion, 41 (5): 296-299.
  7. Tian D An, Lei Y, Huang Zh, etc. (2021). Ascites and Gastric Diseases (in Chinese). Chinese Journal of Digestion, 41 (5): 293-295.
  8. Xia Y F, Zhang Ch Q, Wang G Ch. (2021). A case of POEMS syndrome with ascites as the initial manifestation (in Chinese). Chinese Journal of Internal Medicine, 60 (3): 249-250.
  9. Wang X Y, Yang Y Y. (2021). Ascites and thyroid diseases (in Chinese). Chinese Journal of Digestion, 41 (5): 309-312.
  10. Liu Ch Q, Han D, Xu J. (2021). Analysis of routine cytological examination of ascites in 80 patients with gastric cancer (in Chinese). Laboratory Medicine, 36 (5): 517-518.
  11. Li Y L, Fei G J, Fang X C, et al. (2021). Variant POEMS syndrome manifested by massive ascites (in Chinese). Chinese Journal of Digestion, 41 (9): 629-632.
  12. Shi W J, Xie F, Wan H. (2021). One case of pseudomyxoma peritonei misdiagnosed as hepatitis B cirrhosis with ascites (in Chinese). Chinese Journal of Infectious Diseases, 39 (6): 367-368.
  13. Huo L J. (2021). Ascites and ovarian diseases (in Chinese). Chinese Journal of Digestion, 41 (5): 307-309.
  14. Jiang P, Dou R Ch, Cui Z J, et al. (2021). Predictive value of albumin bilirubin score combined with ascites neutrophil count and procalcitonin in spontaneous bacterial peritonitis in patients with cirrhosis ascites (in Chinese). Journal of Clinical Hepatobiliary Diseases, 37 (9): 2097-2101.
  15. Ji H Ch, Zhang Y M, Cheng Q, et al. (2021). A case of cyclosporidiosis with ascites as the main manifestation (in Chinese). Chinese Journal of Infectious Diseases, 39 (7): 447-448.
  16. Mu H B, Zhang Y F, Chu D M, et al. (2021). Clinical efficacy of nourishing yin and dispersing knot method combined with teicoplanin in patients with liver cirrhosis with intractable ascites and abdominal infection (in Chinese). Chinese patent medicine, 43 (6): 1471-1475.
  17. Zhang M, Liu J, Chen B, etc. (2021). Randomized controlled study of perioperative application of tovaptan in the treatment of ascites due to cirrhosis (in Chinese). Journal of Practical Medicine, 37 (16): 2137-2141.
  18. Ma Y J, Huang Q K, Sun L W, et al. (2021). One case of eosinophilic gastroenteritis with hydrothorax and ascites in children and literature review (in Chinese). Journal of Shandong University (Medical Edition), 59 (7): 125-128.
  19. Guo X Zh. (2021). Ascites and pancreatic diseases (in Chinese). Chinese Journal of Digestion, 41 (5): 299-303.
  20. Chen D F, Wen L Zh. (2021). Ascites and liver diseases (in Chinese). Chinese Journal of Digestion, 41 (5): 303-306.
  21. Hu L, Tang X W, Liu L Y, et al. (2021). Based on the theory of “strengthening the foundation and opening channels”, the effect of dialectical diet on TCM syndrome integral of patients with cirrhosis and ascites (in Chinese). Chinese Journal of Practical Nursing, 37 (29): 2287-2295.
  22. Li J, Zhang Y, Nan P F, et al. (2021). The significance of ascites fluid based cytological characteristics combined with serum CA-125, HE4 and imaging findings in the diagnosis of ovarian cancer (in Chinese). Journal of Diagnostic Pathology, 28 (7): 532-535.
  23. Cheng K, Zhou X D, Yang W R, et al. (2021). Cytological diagnosis of ascites in a case of monomorphic epitheliophilic intestinal T-cell lymphoma (in Chinese). Journal of Diagnostic Pathology, 28 (6): 507-509.
  24. Huang H, Zhang J B, Xu X Y, et al. (2021). Research progress on bacterial ascites disease of cultured turbot and its control methods (in Chinese). Aquatic Science and Technology Information, 48 (2): 112-116.
  25. Jiao X M, Xu H L, Liu Sh S. (1995). Proton transmembrane transport can cause local dehydration on the plasma membrane surface of Ehrlich ascites carcinoma cells (in Chinese). Science Bulletin, 40 (4): 354-357.
  26. Tong Y N, Huang Y J, Zheng J M. (2021). Treatment of refractory ascites due to liver cirrhosis (in Chinese). Clinical Meta, 36 (1): 70-74.
  27. Zi L, Xu Y, Wang Y, etc. (2021). Effects of Lishui Ruangan Decoction, umbilical cord application with traditional Chinese medicine and warm acupuncture on liver function, urine volume and portal vein hemodynamics in patients with liver cirrhosis and ascites (in Chinese). Journal of Liver Diseases of Integrated Traditional Chinese and Western Medicine, 31 (1): 40-43.
  28. Lv Y H, Wu Sh Sh, Wang Zh Ch, et al. (2021). Clinical effect of Rougan Huaxian Granule on ascites caused by hepatitis B cirrhosis and its influence on liver fibrosis and oxidative stress (in Chinese). Western Traditional Chinese Medicine, 34 (3): 19-24.
  29. Guo Y Y, Tian Sh, Dong W G. (2021). The clinical value of F/S CEA, NLR, PLR in differential diagnosis of benign and malignant ascites (in Chinese). Journal of Gastroenterology and Hepatology, 30 (2): 179-183.
  30. Bai J, Zheng Q, Zhang Y B, et al. (2021). Research progress of intraperitoneal drug perfusion in the treatment of malignant ascites (in Chinese). Medical Review, 27 (9): 1740-1746.
  31. Wang Y Y, Chao X, Huang F. (2021). Professor Huang Feng’s experience in treating ascites due to liver cirrhosis (in Chinese). Jilin Journal of Traditional Chinese Medicine, 41 (3): 344-347.
  32. Gan Q, Chen Ch, Chu J, et al. (2021). Effect of negative pressure sealing drainage technology on postoperative ascites leakage in patients with liver cirrhosis (in Chinese). Journal of Armed Police Logistics College (Medical Edition), 30 (5): 61-63.
  33. Guan J Ch, Zhang Zh W, Mao Y X. (2021). Effect of Fuganchun No. 3 Formula on Vasoactive Substances and Aquaporins in Rats with Liver Cirrhosis and Ascites (in Chinese). Journal of Liver Diseases of Integrated Traditional Chinese and Western Medicine, 31 (10): 901-904.
  34. Chen Y R, Zh G Y Zh. (2021). Survival and prognosis analysis of intractable ascites related to PA-HSOS and decompensated cirrhosis treated by transjugular intrahepatic portosystemic shunt (in Chinese). Journal of Bengbu Medical College, 46 (8): 1027-1032.
  35. Xu T T, An Zh T, Li H, et al. (2021). Literature Study on the Distribution of Syndrome and Treatment of Liver Cirrhosis Ascites and the Law of Administration of Umbilical Application Therapy (in Chinese). Western Traditional Chinese Medicine, 34 (6): 85-88.
  36. Xu W B, Shi W B. (2021). Based on the theory of Xin’an Wenbu Peiyuan, discuss the treatment characteristics of ascites due to liver cirrhosis from spleen and kidney (in Chinese). Journal of Liver Diseases of Integrated Traditional Chinese and Western Medicine, 31 (6): 558-559.
  37. Liu J L, Zhang J, Zhang Y H, et al. (2021). The effect of self-made Wenyang Lishui decoction on ascites due to liver cirrhosis of spleen kidney yang deficiency type and its influence on liver function (in Chinese). Journal of Liver Diseases of Integrated Traditional Chinese and Western Medicine, 31 (6): 506-508.
  38. Zhou X, Huang Y H. (2021). Professor Yuan Jinqi, a famous Chinese physician, appreciated the case of liver cirrhosis ascites (in Chinese). Journal of Integrated Chinese and Western Medicine Liver Diseases, 31 (1): 78-80.
  39. Wu Y H, Hao M Q, Li X L, et al. (2021). One case of liver abscess, pleural effusion and ascites with electrolyte disorder treated from lung (in Chinese). Chinese Journal of Traditional Chinese Medicine Information, 28 (5): 120-122.
  40. Zhang Sh L, Shen L J, Zhao H M, et al. (2021). The relationship between serum CK18 FGF-21 level and esophageal varices bleeding and liver function grading in patients with cirrhosis ascites (in Chinese). Hebei Medical Journal, 27 (6): 958-963.
  41. Liu Y L, Zhen Z G, Wang H J, et al. (2021). The predictive value of serum ascites albumin gradient on the risk of EVB in patients with decompensated hepatitis B cirrhosis (in Chinese). Journal of Practical Hepatology, 24 (5): 637-640.